Clinical and Translational Oncology

, Volume 14, Issue 5, pp 333–337 | Cite as

Need to implement a coordinated and multidisciplinary care in the Spanish population at increased risk for colorectal cancer

  • Pedro Pérez Segura
  • Francesc BalaguerEmail author
Educational Series New Trends in Clinical Oncology


Colorectal cancer (CRC) is the second leading cause of cancer death in most developed countries and the most prevalent malignancy when considering men and women together. From a practical standpoint, the individual probability of developing CRC is divided in average risk, which corresponds to individuals aged ≥50 years without additional risk factors (susceptible to population-based screening measures), and high risk, which corresponds to those individuals with any risk factor (hereditary syndromes, personal history and/or family history of adenomas or CRC). This group requires a specific, specialized, and multidisciplinary evaluation in high-risk units. Despite the evidence that screening and surveillance in high-risk forms of CRC is highly effective preventing CRC-deaths, underdiagnosis and lack of application of preventive measures in this population remain the main challenges. The Alliance for Colon Cancer Prevention, an organization that brings together the majority of scientific societies and associations involved in the prevention of this disease in Spain, has gathered a group of experts in various fields involved in the management of patients with CRC. These experts have integrated a discussion forum evaluating the current status and needs in relation to the care of people with an increased risk of CRC in Spain. This document is intended to bring consensus of all involved professionals with the only hope of improving the care of population at risk for CRC.


Colorectal cancer Prevention High-risk Genetics Screening Lynch syndrome 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Curado MP, Edwards B, Shin HR et al (2007) Cancer incidence in five continents. IARC Scientific Publication, No. 160Google Scholar
  2. 2.
    Castells A, Castellvi-Bel S, Balaguer F (2009) Concepts in familial colorectal cancer: where do we stand and what is the future? Gastroenterology 137:404–409PubMedCrossRefGoogle Scholar
  3. 3.
    Balaguer F, Castellvi-Bel S, Castells A et al (2007) Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. Clin Gastroenterol Hepatol 5:379–387PubMedCrossRefGoogle Scholar
  4. 4.
    Piñol V, Andreu M, Castells A et al (2004) Frequency of hereditary non-polyposis colorectal cancer and other colorectal cancer familial forms in Spain: a multicentre, prospective, nationwide study. Eur J Gastroenterol Hepatol 16:39–45PubMedCrossRefGoogle Scholar
  5. 5.
    Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. N Engl J Med 348:919–932PubMedCrossRefGoogle Scholar
  6. 6.
    Castells A, Marzo-Castillejo M, Mascort J et al (2009) Guía de práctica clínica en prevención del cáncer colorrectal. Gastroenterol Hepatol 717.e1–717.e58Google Scholar
  7. 7.
    Andreu Garcia M, Marzo M, Mascort J et al (2009) [Prevention of colorectal cancer]. Aten Primaria 41:127–128PubMedCrossRefGoogle Scholar
  8. 8.
    Balaguer F, Ocana T, Garrell I, Ferrandez A (2008) [High risk clinics: a new concept in colon and rectum cancer prevention]. Med Clin (Barc) 131:382–386CrossRefGoogle Scholar

Copyright information

© Feseo 2012

Authors and Affiliations

  1. 1.Medical Oncology DepartmentHospital Clínico San CarlosMadridSpain
  2. 2.Gastroenterology DepartmentHospital Clínic of Barcelona Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) IDIBAPSBarcelonaSpain

Personalised recommendations